In this study, we proposed that in vivo knockdown of eIF3a attenuated MCT-induced PAH and vascular remodeling, a process achieved by modulating the TGF-β1/SMAD pathway and thus inhibiting the endothelial-to-mesenchymal transition. This evidence concerns the gene EIF3A and pulmonary arterial hypertension.